On Friday, Vaxart Inc (NASDAQ: VXRT) opened lower -11.26% from the last session, before settling in for the closing price of $0.38. Price fluctuations for VXRT have ranged from $0.34 to $1.30 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 1372.05%. Company’s average yearly earnings per share was noted 5.05% at the time writing. With a float of $222.57 million, this company’s outstanding shares have now reached $227.77 million.
Let’s determine the extent of company efficiency that accounts for 115 employees. In terms of profitability, gross margin is 35.26%, operating margin of -230.99%, and the pretax margin is -232.36%.
Vaxart Inc (VXRT) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Vaxart Inc is 2.47%, while institutional ownership is 22.55%. The most recent insider transaction that took place on Jun 18 ’24, was worth 13,578. In this transaction Director of this company bought 20,000 shares at a rate of $0.68, taking the stock ownership to the 78,125 shares.
Vaxart Inc (VXRT) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.08 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 5.05% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -12.51% during the next five years compared to 17.46% growth over the previous five years of trading.
Vaxart Inc (NASDAQ: VXRT) Trading Performance Indicators
Check out the current performance indicators for Vaxart Inc (VXRT). In the past quarter, the stock posted a quick ratio of 0.75. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.68.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.35, a number that is poised to hit -0.10 in the next quarter and is forecasted to reach -0.42 in one year’s time.
Technical Analysis of Vaxart Inc (VXRT)
Looking closely at Vaxart Inc (NASDAQ: VXRT), its last 5-days average volume was 2.97 million, which is a jump from its year-to-date volume of 2.0 million. As of the previous 9 days, the stock’s Stochastic %D was 9.55%. Additionally, its Average True Range was 0.05.
During the past 100 days, Vaxart Inc’s (VXRT) raw stochastic average was set at 0.20%, which indicates a significant decrease from 0.50% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 76.50% in the past 14 days, which was lower than the 105.48% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.5783, while its 200-day Moving Average is $0.6943. However, in the short run, Vaxart Inc’s stock first resistance to watch stands at $0.3770. Second resistance stands at $0.4174. The third major resistance level sits at $0.4382. If the price goes on to break the first support level at $0.3158, it is likely to go to the next support level at $0.2950. Now, if the price goes above the second support level, the third support stands at $0.2546.
Vaxart Inc (NASDAQ: VXRT) Key Stats
There are currently 228,208K shares outstanding in the company with a market cap of 76.79 million. Presently, the company’s annual sales total 28,700 K according to its annual income of -66,950 K. Last quarter, the company’s sales amounted to 15,190 K and its income totaled -11,990 K.
